Phage therapy safety check in serious infection patients
Part of Infections clinical trials.
This study checks the safety of using phage therapy (viruses that target certain bacteria) in adults being treated for serious infections. If you meet the safety rules, your care team may enroll you to help confirm phage treatment is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and are being treated at CRIOAc Lyon for a serious infection with phage therapy
- You agree to take part (you did not refuse participation)
- You weigh at least 46 kg (about 102 lb)
- You are not under legal protection where someone else makes decisions for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well phage therapy (a virus that kills bacteria) works for severe infections. It's for people who received this treatment at a specific hospital in France.
This trial is an organized clinic to help patients request bacteriophage (phage) therapy. It mainly checks that you were referred to the Lyon hospital for a phage therapy request and that you agree to be part of the program.
This trial tests a special treatment using viruses (called phages) that target and kill the bacteria causing a long-term joint replacement infection. It's designed for people who have tried many other treatments without success.
This trial tests a new treatment using viruses that attack bacteria (called phages) to fight infections in knee or hip replacements caused by Staphylococcus aureus. It may help people who still have the infection after a surgery to clean the joint, called DAIR.
This study tests a treatment using bacteriophages (special viruses that kill bacteria) for infections that happen around metal implants in bones. It aims to see if this approach can safely clear these hard-to-treat infections.
This study tests whether adding a treatment with special viruses (called phages) to standard antibiotic care can help clear a joint infection more effectively after surgery. The goal is to improve your chances of keeping the artificial hip or knee and avoid the need for more procedures.
Hear when a new Prosthetic Joint Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.